Regulatory Dashboard | GMO Regulatory Considerations for Advanced Therapies in Europe

In the European Union (EU), gene therapy medicinal products (GTMP) are a subset of advanced therapy medicinal products (ATMPs) and may consist of or contain genetically modified organisms (GMOs). The EU GMO frameworks were developed to address environmental concerns related to GMOs for agricultural use.

This site uses cookies to personalize and customize your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services
Secured By miniOrange